Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
Vroege behandeling van milde tot matige COVID-19 met sotrovimab reduceert risico op progressie
apr 2022 | Pneumonie, Virale infecties